Real-world data insights shaping the future of biopharma

Discover how Labcorp leaders use real-world data and diagnostics to drive credible evidence generation across the evolving biopharma landscape.

As the healthcare and biopharma landscape continues to evolve, real-world data is playing an increasingly critical role in shaping development strategies, evidence generation, patient identification, and access pathways.

Through this executive spotlight series, Labcorp leaders share perspectives on the trends, challenges, and opportunities influencing the future of real-world data and diagnostics-driven insights across biopharma.

These conversations explore topics including:

• Evidence generation: Real-world evidence, longitudinal patient journeys, and diagnostics-driven insights.
• Precision medicine: Biomarker strategies, genetics, and personalized healthcare.
• The future of data: AI-enabled analytics, interoperable data ecosystems, and the next generation of evidence generation.

Featured Interview

Dan Jacob
VP & General Manager, Real World Data
In this discussion, Dan Jacob shares perspectives on how real-world data is evolving from a supplementary capability to a strategic driver of evidence generation and decision-making across biopharma.